Rs 1,100 Calls on Zydus Lifesciences Ltd See Heavy Activity — What the Strike Price Tells You

Options Event and Cash Market Price Action

The most active call options on Zydus Lifesciences Ltd on 20 May 2026 were those with a strike price of Rs 1,100, with 12,866 contracts traded. This activity generated a turnover of approximately ₹1464.79 lakhs. The underlying stock closed at Rs 1,087.55, just below the strike price, while the expiry is set for 26 May 2026, less than a week away. The Rs 1,080 strike also saw significant activity with 9,872 contracts traded, but the Rs 1,100 strike dominated volume and open interest.

Such concentrated call buying close to expiry suggests a near-term directional bet on the stock’s upside. The stock’s 6.33% gain on the day, outperforming its sector by 4.89%, aligns with this surge in call activity — does this confirm a momentum-driven rally or is the options market anticipating further gains?

Strike Price and Moneyness Analysis

The Rs 1,100 strike price is slightly out-of-the-money (OTM) relative to the closing price of Rs 1,087.55, while the Rs 1,080 strike is just in-the-money (ITM). The prominence of the Rs 1,100 strike calls indicates speculative upside positioning, betting on the stock crossing this level before expiry. OTM calls typically represent a leveraged bet on a price move beyond the current level, reflecting optimism about a near-term breakout.

Meanwhile, the Rs 1,080 strike’s substantial volume and open interest suggest some hedging or more conservative bullish bets. The proximity of the stock price to these strikes means the options are highly sensitive to price movements, especially given the expiry is only six trading days away — how might this gamma sensitivity influence volatility in the coming sessions?

Open Interest and Contracts Analysis

Open interest at the Rs 1,100 strike stands at 2,168 contracts, while 12,866 contracts traded on the day. This results in a contracts-to-open interest ratio of nearly 5.9:1, signalling a significant influx of fresh positions rather than mere recycling of existing ones. Such a high ratio close to expiry points to urgent directional bets rather than long-term hedging.

At the Rs 1,080 strike, open interest is 1,151 contracts against 9,872 traded, a ratio of approximately 8.6:1, reinforcing the theme of fresh positioning. The elevated open interest at these strikes also indicates that these levels are focal points for traders, potentially acting as short-term support and resistance zones.

Cash Market Context: Momentum and Moving Averages

Zydus Lifesciences Ltd has been on a strong upward trajectory, gaining 8.26% over the past two sessions and hitting a new 52-week high of Rs 1,083 on 20 May. The stock is trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling robust technical strength. This alignment of price action with call option activity suggests the derivatives market is reflecting genuine bullish momentum rather than speculative noise.

The stock opened with a gap-up of 4.64% and touched an intraday high of Rs 1,083, with volume weighted average price skewed towards the lower end, indicating buying interest throughout the session. Such price behaviour supports the notion that the call buying is not disconnected from the cash market — is this momentum sustainable or nearing exhaustion?

Delivery Volume and Market Participation

Delivery volumes on 19 May surged to 18.98 lakh shares, a 180.25% increase over the 5-day average, signalling strong investor participation in the cash market. This rise in delivery volume alongside the call option surge indicates that the bullish sentiment is supported by genuine buying interest rather than purely speculative derivatives activity.

Liquidity remains adequate, with the stock able to handle trade sizes of around ₹6.17 crore based on 2% of the 5-day average traded value. This ensures that the price moves are less likely to be distorted by illiquidity, lending credibility to the observed momentum.

Key Data at a Glance

Interpreting the Combined Signals

The heavy call option activity at the Rs 1,100 strike, combined with the stock’s strong price rally and elevated delivery volumes, paints a picture of near-term bullish conviction. The contracts-to-open interest ratio suggests that much of this activity is fresh money entering the market, rather than existing holders adjusting positions. The proximity of expiry adds urgency to these bets, indicating traders expect meaningful price movement within days.

However, the stock remains just below the Rs 1,100 strike, making these calls slightly out-of-the-money and thus more speculative. The strong technical backdrop, with the stock trading above all major moving averages, supports the possibility of a breakout — but is this momentum a signal to join the rally or a cue to watch for a potential pullback?

Summary

The surge in Rs 1,100 call contracts on Zydus Lifesciences Ltd ahead of the 26 May expiry reflects a concentrated short-term directional bet on the stock’s upside. The options market activity is well supported by the cash market’s strong price gains, rising delivery volumes, and positive technical indicators. While the strike price is slightly out-of-the-money, the volume and open interest data point to fresh bullish positioning rather than mere hedging or position unwinding. This alignment of derivatives and cash market signals provides a comprehensive view of the current market sentiment surrounding the stock.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today